Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 33Neoplasms 25Prostatic Neoplasms 16Colorectal Neoplasms 13Lung Neoplasms 11Multiple Myeloma 9Head and Neck Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Hematologic Neoplasms 5Gastrointestinal Neoplasms 5Advanced Cancer 5Uterine Cervical Neoplasms 4Smoking Cessation 4Ovarian Neoplasms 4Melanoma 4Leukemia 4Colonic Neoplasms 4Anxiety Disorders 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Neoplasms, Plasma Cell 3Motor Activity 3Lymphoma, Follicular 3Lymphedema 3

Interventions

proxalutamide 1XAV-19 1Standard of Care 1Sodium Chloride 1BNT162 Vaccine 12019-nCoV Vaccine mRNA-1273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Severe Acute Respiratory Syndrome × Standard of Care × Clear all
NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Applied Biology, Inc.

Phase NA Completed
268 enrolled 8 charts
Genitourinary

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡